300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Climate
Fashion
Life Science
Food and Beverage
Publishing
LGBT
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Cannabis
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Celebrity
Android
Proptech
Impact
Sustainability
Hardware
Enterprise
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Bangladesh
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Bahamas
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Belarus
Finland
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Amanda Gett Chaperot, Partner at Kurma Partners

Amanda Gett Chaperot

Partner @ Kurma Partners

Paris, France

Amanda Gett Chaperot is a Series B investor at Kurma Partners in Paris focused on Medical and Biopharma. Amanda Gett Chaperot is based out of Paris, Ile-de-France and is the Partner of Kurma Partners. Amanda previously worked at Seventure Partners as a Partner. Amanda Gett Chaperot attended the University of Sydney. Amanda Gett Chaperot has been received Best New Investigator Award.

Total investments:
1
Last investment:
Lead investor:
100%

Last updated:

Industries Amanda Gett Chaperot invests in

MedicalBiopharmaBiotechnologyPharmaceutical

Stages Amanda Gett Chaperot invests in

Series B

Countries Amanda Gett Chaperot invests in

Singapore

Contacts

TypeContactValidation
Work email
Personal email
Work phone
Personal phone
Socials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Medical 1 (100%)
  • Biopharma 1 (100%)
  • Biotechnology 1 (100%)
  • Pharmaceutical 1 (100%)

Investments

CompanyDescriptionRoundLinks
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts. $45M / Series B / May 06, 2025

Co-Investors

Kurma Partners

About Kurma Partners

VC Fund · Paris, France

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Kurma Partners Contacts

NameEmailPhoneSocials
Alain Horvais
Alain Horvais Partner
Amine Marouf
Amine Marouf Principal
Peter Neubeck
Peter Neubeck Partner

Sign up to unlock verified contacts

Unlock Contacts

See all 14 contacts →

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Climate
Fashion
Life Science
Food and Beverage
Publishing
LGBT
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Cannabis
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Celebrity
Android
Proptech
Impact
Sustainability
Hardware
Enterprise
Biotech
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Japan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Ireland
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Argentina
Qatar
Angola
Cyprus
Barbados
Belgium
Jordan
Ethiopia
Bangladesh
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Estonia
Bolivia
Bahamas
Italy
Belize
Algeria
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Belarus
Finland
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Amanda Gett Chaperot invest in?

Amanda Gett Chaperot invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Amanda Gett Chaperot?

Public channels for Amanda Gett Chaperot include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

When did Amanda Gett Chaperot last invest?

The most recent investment recorded for Amanda Gett Chaperot closed in May 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Amanda Gett Chaperot Amanda Gett Chaperot Find email